Post by Allogenica

Advancing next‑gen cell therapies requires not only better treatments but smarter preclinical models. 🔬🚀 Together with INOVOTION and Université Grenoble Alpes, Allogenica's researchers highlight the power of the chicken CAM assay as an innovative in vivo platform for CAR‑T evaluation 🐔🧪, capturing tumor inhibition, metastasis control, angiogenesis, and immune responses all in one model. 🎯 This work shows how combining advanced cell‑therapy engineering with innovative translational models can accelerate future immunotherapies. ⚡ At Allogenica, we’re building universal #next‑generation T‑cell therapies to broaden the impact of cellular #immunotherapy. 🌍💪